{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T01:40:06Z","timestamp":1722994806327},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/cgt.2016.31","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T10:22:12Z","timestamp":1469787732000},"page":"278-283","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel REIC\/Dkk-3-encoding adenoviral vector as a promising therapeutic agent for pancreatic cancer"],"prefix":"10.1038","volume":"23","author":[{"given":"H","family":"Sawahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Shiraha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Nagahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Iwamuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Takaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nouso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Kumon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"BFcgt201631_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrclinonc.2013.66","volume":"10","author":"J Werner","year":"2013","unstructured":"Werner J, Combs SE, Springfeld C, Hartwig W, Hackert T, Buchler MW . Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol 2013; 10: 323\u2013333.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFcgt201631_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A . Cancer statistics. 2013 CA Cancer J Clin 2013; 63: 11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"BFcgt201631_CR3","doi-asserted-by":"publisher","first-page":"e26662","DOI":"10.4161\/onci.26662","volume":"2","author":"B Salman","year":"2013","unstructured":"Salman B, Zhou D, Jaffee EM, Edil BH, Zheng L . Vaccine therapy for pancreatic cancer. Oncoimmunology 2013; 2: e26662.","journal-title":"Oncoimmunology"},{"key":"BFcgt201631_CR4","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/PPO.0b013e3182756903","volume":"18","author":"KC Soares","year":"2012","unstructured":"Soares KC, Zheng L, Edil B, Jaffee EM . Vaccines for pancreatic cancer. Cancer J 2012; 18: 642\u2013652.","journal-title":"Cancer J"},{"key":"BFcgt201631_CR5","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/bjc.2014.131","volume":"110","author":"T Hamada","year":"2014","unstructured":"Hamada T, Nakai Y, Yasunaga H, Isayama H, Matsui H, Takahara N et al. Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy. Br J Cancer 2014; 110: 1943\u20131949.","journal-title":"Br J Cancer"},{"key":"BFcgt201631_CR6","first-page":"545","volume":"8","author":"MW Saif","year":"2007","unstructured":"Saif MW . Controversies in the adjuvant treatment of pancreatic adenocarcinoma. JOP 2007; 8: 545\u2013552.","journal-title":"JOP"},{"key":"BFcgt201631_CR7","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s00595-013-0752-9","volume":"44","author":"M Kanada","year":"2014","unstructured":"Kanada M, Fujii T, Takami H, Suenaga M, Inokawa Y, Yamada S et al. The combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients. Surg Today 2014; 44: 1692\u20131701.","journal-title":"Surg Today"},{"key":"BFcgt201631_CR8","doi-asserted-by":"publisher","first-page":"5513","DOI":"10.1200\/JCO.2009.24.2446","volume":"27","author":"D Cunningham","year":"2009","unstructured":"Cunningham D, Chau I, Stocken DD, Valle JW, Smith D, Steward W et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol 2009; 27: 5513\u20135518.","journal-title":"J Clin Oncol"},{"key":"BFcgt201631_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/bbrc.1999.2067","volume":"268","author":"T Tsuji","year":"2000","unstructured":"Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M . A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 2000; 268: 20\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcgt201631_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/jgh.12501","volume":"29","author":"D Uchida","year":"2014","unstructured":"Uchida D, Shiraha H, Kato H, Nagahara T, Iwamuro M, Kataoka J et al. Potential of adenovirus-mediated REIC\/Dkk-3 gene therapy for use in the treatment of pancreatic cancer. J Gastroenterol Hepatol 2014; 29: 973\u2013983.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcgt201631_CR11","first-page":"117","volume":"19","author":"I Nozaki","year":"2001","unstructured":"Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M et al. Reduced expression of REIC\/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 2001; 19: 117\u2013121.","journal-title":"Int J Oncol"},{"key":"BFcgt201631_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/01.ju.0000101047.64379.d4","volume":"171","author":"K Kurose","year":"2004","unstructured":"Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, Kariyama R et al. Decreased expression of REIC\/Dkk-3 in human renal clear cell carcinoma. J Urol 2004; 171: 1314\u20131318.","journal-title":"J Urol"},{"key":"BFcgt201631_CR13","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1158\/0008-5472.CAN-05-0829","volume":"65","author":"F Abarzua","year":"2005","unstructured":"Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S et al. Adenovirus-mediated overexpression of REIC\/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 2005; 65: 9617\u20139622.","journal-title":"Cancer Res"},{"key":"BFcgt201631_CR14","doi-asserted-by":"publisher","first-page":"8333","DOI":"10.1158\/0008-5472.CAN-08-0080","volume":"68","author":"Y Kashiwakura","year":"2008","unstructured":"Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M et al. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC\/Dickkopf-3-induced apoptosis. Cancer Res 2008; 68: 8333\u20138341.","journal-title":"Cancer Res"},{"key":"BFcgt201631_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1215\/15228517-2008-016","volume":"10","author":"Y Mizobuchi","year":"2008","unstructured":"Mizobuchi Y, Matsuzaki K, Kuwayama K, Kitazato K, Mure H, Kageji T et al. REIC\/Dkk-3 induces cell death in human malignant glioma. Neuro Oncol 2008; 10: 244\u2013253.","journal-title":"Neuro Oncol"},{"key":"BFcgt201631_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/cgt.2008.58","volume":"16","author":"K Kawasaki","year":"2009","unstructured":"Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y et al. REIC\/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7\/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 2009; 16: 65\u201372.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201631_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3892\/ol.2013.1777","volume":"7","author":"M Wanatabe","year":"2014","unstructured":"Wanatabe M, Nasu Y, Kumon H . Adenovirus-mediated REIC\/Dkk-3 gene therapy: development of an autologous cancer vaccination therapy (review). Oncol Lett 2014; 7: 595\u2013601.","journal-title":"Oncol Lett"},{"key":"BFcgt201631_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4137\/CMO.S23252","volume":"9","author":"H Kumon","year":"2015","unstructured":"Kumon H, Sasaki K, Ariyoshi Y, Sadahira T, Ebara S, Hiraki T et al. Ad-REIC gene therapy: promising results in a patient with metastatic CRPC following chemotherapy. Clin Med Insights Oncol 2015; 9: 31\u201338.","journal-title":"Clin Med Insights Oncol"},{"key":"BFcgt201631_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3892\/or.2013.2958","volume":"31","author":"M Watanabe","year":"2014","unstructured":"Watanabe M, Sakaguchi M, Kinoshita R, Kaku H, Ariyoshi Y, Ueki H et al. A novel gene expression system strongly enhances the anticancer effects of a REIC\/Dkk-3-encoding adenoviral vector. Oncol Rep 2014; 31: 1089\u20131095.","journal-title":"Oncol Rep"},{"key":"BFcgt201631_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa H, Yamamura K, Miyazaki J . Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193\u2013199.","journal-title":"Gene"},{"key":"BFcgt201631_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1073\/pnas.92.1.160","volume":"92","author":"K Araki","year":"1995","unstructured":"Araki K, Araki M, Miyazaki J, Vassalli P . Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci USA 1995; 92: 160\u2013164.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201631_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0378-1119(01)00550-9","volume":"272","author":"ZL Xu","year":"2001","unstructured":"Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T, Hayakawa T et al. Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 2001; 272: 149\u2013156.","journal-title":"Gene"},{"key":"BFcgt201631_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0168-3659(02)00059-7","volume":"81","author":"ZL Xu","year":"2002","unstructured":"Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T, Hayakawa T . Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector. J Control Release 2002; 81: 155\u2013163.","journal-title":"J Control Release"},{"key":"BFcgt201631_CR24","doi-asserted-by":"publisher","first-page":"14236","DOI":"10.1074\/jbc.M808002200","volume":"284","author":"M Sakaguchi","year":"2009","unstructured":"Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H et al. Overexpression of REIC\/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem 2009; 284: 14236\u201314244.","journal-title":"J Biol Chem"},{"key":"BFcgt201631_CR25","first-page":"492372","volume":"2013","author":"E Niccolai","year":"2012","unstructured":"Niccolai E, Prisco D, D\u2019Elios MM, Amedei A . What is recent in pancreatic cancer immunotherapy? Biomed Res Int 2012; 2013: 492372.","journal-title":"Biomed Res Int"},{"key":"BFcgt201631_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00595-012-0179-8","volume":"43","author":"CE Kitami","year":"2013","unstructured":"Kitami CE, Kurosaki I, Kawachi Y, Nihei K, Tsuchiya Y, Nomura T et al. Portal vein infusion chemotherapy with gemcitabine after surgery for pancreatic cancer. Surg Today 2013; 43: 33\u201339.","journal-title":"Surg Today"},{"key":"BFcgt201631_CR27","first-page":"555","volume":"9","author":"JR Hecht","year":"2003","unstructured":"Hecht JR, Bedford R, Abbruzzese JL, Lahoti S, Reid TR, Soetikno RM et al. A phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clin Cancer Res 2003; 9: 555\u2013561.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201631_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00006676-199707000-00004","volume":"15","author":"A Block","year":"1997","unstructured":"Block A, Chen SH, Kosai K, Finegold M, Woo SL . Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors. Pancreas 1997; 15: 25\u201334.","journal-title":"Pancreas"},{"key":"BFcgt201631_CR29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1089\/hum.1997.8.9-1105","volume":"8","author":"K Aoki","year":"1997","unstructured":"Aoki K, Yoshida T, Matsumoto N, Ide H, Hosokawa K, Sugimura T et al. Gene therapy for peritoneal dissemination of pancreatic cancer by liposomemediated transfer of herpes simplex virus thymidine kinase gene. Hum Gene Ther 1997; 8: 1105\u20131113.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201631_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/1521-2254(200009\/10)2:5<361::AID-JGM125>3.0.CO;2-7","volume":"2","author":"K Makinen","year":"2000","unstructured":"Makinen K, Loimas S, Wahlfors J, Alhava E, J\u00e4nne J . Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer. J Gene Med 2000; 2: 361\u2013367.","journal-title":"J Gene Med"},{"key":"BFcgt201631_CR31","first-page":"693","volume":"9","author":"D Makower","year":"2003","unstructured":"Makower D, Rozenblit A, Kaufman H, Edelman M, Lane ME, Zwiebel J et al. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin Cancer Res 2003; 9: 693\u2013702.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201631_CR32","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/sj.cgt.7700830","volume":"12","author":"H Kasuya","year":"2005","unstructured":"Kasuya H, Takeda S, Nomoto S, Nakao A . The potential of oncolytic virus therapy for pancreatic cancer. Cancer Gene Ther 2005; 12: 725\u2013736.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201631_CR33","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1245\/s10434-013-3329-3","volume":"21","author":"K Yamamura","year":"2014","unstructured":"Yamamura K, Kasuya H, Sahin TT, Tan G, Hotta Y, Tsurumaru N et al. Combination treatment of human pancreatic cancer xenograft models with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib and oncolytic herpes simplex virus HF10. Ann Surg Oncol 2014; 21: 691\u2013698.","journal-title":"Ann Surg Oncol"},{"key":"BFcgt201631_CR34","first-page":"657","volume":"34","author":"M Watanabe","year":"2009","unstructured":"Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA et al. Immunological aspects of REIC\/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 2009; 34: 657\u2013663.","journal-title":"Int J Oncol"},{"key":"BFcgt201631_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/cgt.2010.65","volume":"18","author":"A Nakao","year":"2011","unstructured":"Nakao A, Kasuya H, Sahin TT, Nomura N, Kanzaki A, Misawa M et al. A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer. Cancer Gene Ther 2011; 18: 167\u2013175.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201631_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/030089168607200112","volume":"72","author":"T Livraghi","year":"1986","unstructured":"Livraghi T, Baietta E, Matricardi L, Villa E, Lovati R, Vettori C . Fine needle percutaneous intratumoral chemotherapy under ultrasound guidance: a feasibility study. Tumori 1986; 72: 81\u201387.","journal-title":"Tumori"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201631","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T12:07:05Z","timestamp":1647950825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFcgt201631"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2016.31","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]},"assertion":[{"value":"14 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MW, MS, YN and HK own stocks in Momotaro-Gene. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}